Mazzotta E, Tavano L, Muzzalupo R
There is a proposal to allow Medicare to cover weight loss drugs for the treatment of obesity, so the coverage exclusion may be removed in the future
In the complementary study from the same research group (Batistel et al., 2019), Met supply during late gestation also led to sex-dependent responses in placental metabolism and DNA methylation, improving the calf birth body weight (Batistel et al., 2019)
Nature 429 , 771776 (2004)
Does it work
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a breakthrough therapy for obesity, overweight, and other associated health conditions, delivering unprecedented weight loss in clinical trials